What is HOLX's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 16.97B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for HOLX?

P/E (TTM) is 31.20 and 52-week range is $71.49 to $76.07 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s HOLX figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for HOLX?

The company profile lists revenue (TTM) near $4.08B, net income (TTM) near $538M, EPS (TTM) near $2.41 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Hologic Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Marlborough, Massachusetts, US, 223.2M shares outstanding, ISIN US4364401012 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Hologic Inc

$HOLX

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focus on women’s health and well-being through early detection and treatment. The company is headquartered in Marlborough, Massachusetts and currently employs 7,070 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.

Employees

7,070

Website

www.hologic.com

IPO

1990-03-01

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)